Subscriber Login
DRIP Tools
List of No-Loads and their
Quadrix ratings
Intermediate Potential Risk Indicator
DRIP Ratings & Web site links
DRIP Investor Picks Stocks That Go Up!
My Editor's Portfolio in the first issue of DRIP Investor consisted of six stocks. All but Browning-Ferris (which was aquired in 1999) remain in my portfolio. Check out how these remaining five stocks have performed (all prices are adjusted for stock splits):
Will our selection process work for you? See for yourself!
Stock |
8/3/1992 |
5/10/2013 |
% Gain |
Bristol-Myers |
$17.65 |
$40.49 |
129.4% |
Exxon Mobil |
$16.06 |
$90.14 |
461.3% |
PepsiCo |
$18.69 |
$83.00 |
344.1% |
Proctor & Gamble |
$12.69 |
$78.76 |
520.7% |
Walgreen |
$4.45 |
$48.72 |
994.8% |
And these numbers don't reflect dividends that were reinvested or the fact that I owned and accumulated shares in a very cost-friendly way via DRIPs. Those are crucial points to understand. The combination of long-term (one might even call it the much-maligned "buy-and-hold") investing, dividend reinvestment, dollar-cost averaging, and no-cost/low-cost investing is a powerful strategy for wealth creation. It worked for me, and it has worked for many of the investors who started with our Charter issue 20 years ago and are still with us today!
You need to see for yourself. Subscribe to DRIP Investor today.
ATTENTION
Wall Street Journal Readers
Your FREE LIST of No-Load Stocks
Commentary
6/17/13
Don’t Bail on Banks
Charles Carlson, CFA
Editor, DRIP Investor Newsletter
Rising interest rates are worrying bank investors, as higher rates will put a dent in the refi and mortgage markets – two drivers of recent. . .
